SFX by Ex Libris Inc.

Title:	SPTLC1 is mutated in hereditary sensory neuropathy, type 1
Source:	Nature Genetics [1061-4036] Bejaoui, Khemissa yr:2001

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Dawkins, Jennifer L. "Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I." Nature genetics 27.3 (2001): 309-312.
description	2.	Liu, J. "Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy." Nature genetics 20.1 (1998): 31-6.
description	3.	Slaugenhaupt, S A A. "Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia." American Journal of Human Genetics 68.3 (2001): 598-605.
description	4.	Hilz, M. "Sympathetic skin response differentiates hereditary sensory autonomic neuropathies III and IV." Neurology 52.8 (1999): 1652-7.
description	5.	Bejaoui, K. "Hereditary sensory neuropathy type 1 mutations confer dominant negative effects on serine palmitoyltransferase, critical for sphingolipid synthesis." The journal of clinical investigation 110.9 (2002): 1301-1308.
description	6.	Auer Grumbach, M. "Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype." European journal of medical genetics 56.5 (2013): 266-9.
description	7.	Penno, A. "Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids." The Journal of biological chemistry 285.15 (2010): 11178-11187.
description	8.	Matuda, S. "A novel protein found in the I bands of myofibrils is produced by alternative splicing of the DLST gene." Biochimica et biophysica acta. General subjects 1800.1 (2010): 31-9.
description	9.	Bansal, D. "Defective membrane repair in dysferlin-deficient muscular dystrophy." Nature 423.6936 (2003): 168-72.
description	10.	Gugasyan. "Prevention of splenic granuloma formation in adjuvant arthritis by 2- acetyl-4-tetrahydroxybutylimidazole (THI)." Immunology letters 58.3 (1997): 133-.
description	11.	Lennon, Niall J J. "Dysferlin interacts with annexins A1 and A2 and mediates sarcolemmal wound-healing." The Journal of biological chemistry 278.50 (2004): 50466-73.
description	12.	Lee, G. "Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs." Nature 461.7262 (2009): 402-406.
description	13.	Glover, L. "Dysferlin in membrane trafficking and patch repair." Traffic 8.7 (2007): 785-94.
description	14.	Dedov, Vadim N. "Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells." Biochimica et biophysica acta. Molecular basis of disease 1688.2 (2004): 168-175.
description	15.	Trindade, V M T. "Undernutrition decreases serine palmitoyltransferase activity in developing rat hypothalamus." Annals of Nutrition & Metabolism 43.3 (1999): 152-.
description	16.	Gable, Gongshe n. "Mutations in the yeast LCB1 and LCB2 genes, including those corresponding to the hereditary sensory neuropathy type I mutations, dominantly inactivate serine palmitoyltransferase." The Journal of biological chemistry 277.12 (2002): 10194-10200.
description	17.	Klein, Caroline M M. "The spectrum of autoimmune autonomic neuropathies." Annals of neurology 53.6 (2003): 752-8.
description	18.	Fabrizio, P. "The Evolutionarily Conserved Core Design of the Catalytic Activation Step of the Yeast Spliceosome." Molecular cell 36.4 (2009): 593-608.
description	19.	Tanner, K. "Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat." The journal of neuroscience 18.16 (1998): 6480-91.
description	20.	Brunt, P. "Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature." Medicine 49.5 (1970): 343-374.